Product
AMG 531
3 clinical trials
2 indications
Indication
Immune Thrombocytopenic PurpuraIndication
ThrombocytopeniaClinical trial
A Randomized, Double Blind, Placebo Controlled Phase 3 Study Evaluating the Efficacy and Safety of AMG 531 in Thrombocytopenic Japanese Subjects With Immune (Idiopathic) Thrombocytopenic PurpuraStatus: Completed, Estimated PCD: 2009-04-13
Clinical trial
A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Prior to SplenectomyStatus: Completed, Estimated PCD: 2006-12-01
Clinical trial
A Randomized, Placebo Controlled Study Evaluating the Efficacy and Safety of AMG 531 Treatment of Thrombocytopenic Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Refractory to SplenectomyStatus: Completed, Estimated PCD: 2006-09-01